(NASDAQ: DRIO) Dariohealth's forecast annual revenue growth rate of 34.89% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 6.33%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.23%.
Dariohealth's revenue in 2024 is $20,352,000.On average, 1 Wall Street analysts forecast DRIO's revenue for 2024 to be $965,420,624, with the lowest DRIO revenue forecast at $965,420,624, and the highest DRIO revenue forecast at $965,420,624.
In 2025, DRIO is forecast to generate $1,218,037,549 in revenue, with the lowest revenue forecast at $1,218,037,549 and the highest revenue forecast at $1,218,037,549.